These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6140480)

  • 41. [Immunogenicity and long-term effectiveness of the hepatitis B vaccine in newborns from HBsAg-positive mothers].
    Torres JM; Bruguera M; Fos E; Mayor A; Hierro FR
    Med Clin (Barc); 1990 Sep; 95(7):247-9. PubMed ID: 2149403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections.
    Brunell PA; Bass JW; Daum RS; Gamble WB; Giebink GS; Hall CB; Peter G; Plotkin SA; Hinman AR; Petricciani JC
    Pediatrics; 1985 Feb; 75(2):362-4. PubMed ID: 3155834
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevention of viral hepatitis B in exposure to carriers of HBsAG in Plzen in 1998].
    Pazdiora P; Petríková V; Fránová D
    Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):153-9. PubMed ID: 10658343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RIA evaluation of antibody levels in neonates from HBsAg-positive mothers after active, passive, and combined immunoprophylaxis.
    Scaravelli C; Calligari G; Mariani G; Bianchi E; Biraghi V; Lucchesi P; De Leo G
    Gynecol Obstet Invest; 1984; 17(4):208-12. PubMed ID: 6233208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Five years of vaccination campaign against hepatitis B in Italy in infants of hepatitis B surface antigen carrier mothers.
    Stroffolini T; Pasquini P
    Ital J Gastroenterol; 1990 Aug; 22(4):195-7. PubMed ID: 2131945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].
    Zecca G; Motti G; Manzoni C; Del Curto E
    Minerva Pediatr; 1985 Sep; 37(17):593-6. PubMed ID: 2934613
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatitis B vaccine inhibiting vertical transmission of hepatitis B virus].
    Tu SX
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):358-60, 388. PubMed ID: 1804608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH; Wang LY; Hu CT; Huang SC; Huang LC; Lin SS; Chiang YM; Liu TT; Chen CL
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vertical transmission of hepatitis B virus. 1: Hepatitis B screening in pregnancy in the Rostock district].
    Hülsse C; Jährig D; Jülich WD; Müller W; Rohde S; Scholz B
    Z Arztl Fortbild (Jena); 1990; 84(5):203-6. PubMed ID: 2375157
    [No Abstract]   [Full Text] [Related]  

  • 51. [Results and experiences of HBsAG determination with passive hemagglutination (Serotest SSW/HBsAG)].
    Steinwehr D; Jülich WD; Kober P
    Z Arztl Fortbild (Jena); 1988; 82(9):409-12. PubMed ID: 3218267
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatitis B screening in pregnant patients and their children. A Greifswald perinatology-pediatric study. II. Pediatric findings].
    Jährig VD; Kadow I; Jülich WD; Meisel H
    Zentralbl Gynakol; 1989; 111(10):651-7. PubMed ID: 2526444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.
    Gerlich WH
    Med Microbiol Immunol; 2015 Feb; 204(1):39-55. PubMed ID: 25523195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 55. Testing pregnant women for HBsAg: a pilot study in Manitoba.
    Sekla LH; Hammond G; Stackiw W; Eibisch G; Fast M
    Can Dis Wkly Rep; 1988 Aug; 14(31):137-40. PubMed ID: 3242888
    [No Abstract]   [Full Text] [Related]  

  • 56. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Routine studies of pregnant women for HBsAg for the prevention of hepatitis B virus infection of neonates].
    Katchaki JN; Siem TH; Brouwer R; van der Waarde KM
    Ned Tijdschr Geneeskd; 1982 Feb; 126(9):395-7. PubMed ID: 7063069
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.
    Beasley RP; Hwang LY; Lin CC; Stevens CE; Wang KY; Sun TS; Hsieh FJ; Szmuness W
    Lancet; 1981 Aug; 2(8243):388-93. PubMed ID: 6115159
    [No Abstract]   [Full Text] [Related]  

  • 60. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.
    Okun NB; Larke RP; Waters JR; Joffres MR
    CMAJ; 1990 Dec; 143(12):1317-21. PubMed ID: 2147576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.